GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Capex-to-Revenue

Sonoscape Medical (SZSE:300633) Capex-to-Revenue : 0.12 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sonoscape Medical's Capital Expenditure for the three months ended in Mar. 2024 was ¥-57.55 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥479.33 Mil.

Hence, Sonoscape Medical's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.12.


Sonoscape Medical Capex-to-Revenue Historical Data

The historical data trend for Sonoscape Medical's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Capex-to-Revenue Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.13 0.11 0.11 0.08

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.07 0.12 0.06 0.12

Competitive Comparison of Sonoscape Medical's Capex-to-Revenue

For the Medical Devices subindustry, Sonoscape Medical's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoscape Medical's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonoscape Medical's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sonoscape Medical's Capex-to-Revenue falls into.



Sonoscape Medical Capex-to-Revenue Calculation

Sonoscape Medical's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-176.987) / 2120.252
=0.08

Sonoscape Medical's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-57.545) / 479.334
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical  (SZSE:300633) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Sonoscape Medical Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Executives
Zhou Wen Ping Directors, executives
Huang Yi Bo Directors, executives
Li Hao Directors, executives
Chen Zhi Qiang Director
Wu Kun Xiang Directors, executives
Liu Ying Fang Director

Sonoscape Medical (SZSE:300633) Headlines

No Headlines